Document and Entity Information
Document Type
Document Annual Report
Document Period End Date
Document Transition Report
Entity File Number
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
City Area Code
Local Phone Number
Title of 12(b) Security
Trading Symbol
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
ICFR Auditor Attestation Flag
Document Financial Statement Error Correction [Flag]
Entity Shell Company
Entity Public Float
Entity Common Stock, Shares Outstanding
Auditor Firm ID
Auditor Name
Auditor Location
Entity Central Index Key
Current Fiscal Year End Date
Document Fiscal Year Focus
Document Fiscal Period Focus
Amendment Flag
CONSOLIDATED BALANCE SHEETS
Statement [Table]
Statement [Table]
Statement [Line Items]
Statement
Assets [Abstract]
ASSETS
Assets, Current [Abstract]
Current Assets:
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Nontrade Receivables, Current
Other accounts receivable
Prepaid Expense and Other Assets, Current
Prepaid expenses and other current assets
Assets, Current
Total current assets
Assets, Noncurrent [Abstract]
Long-Term Assets:
Other Assets, Noncurrent
Other long-term assets
Restricted Cash, Noncurrent
Restricted Cash
Operating Lease, Right-of-Use Asset
Operating lease right of use asset (Note 4)
Operating lease right of use asset
Property, Plant and Equipment, Net
Depreciated cost
Property and Equipment, Net (Note 5)
Assets, Noncurrent
Total Long-Term Assets
Assets
Total assets
Liabilities and Equity [Abstract]
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Liabilities, Current [Abstract]
Current Liabilities:
Accounts Payable, Current
Accounts payables
Accrued Liabilities, Current
Accrued expenses
Short-Term Debt
Short-term loans (Note 11)
Operating Lease, Liability, Current
Operating lease liability (Note 4)
Employee-related Liabilities, Current
Employees related liability
Liabilities, Current
Total current liabilities
Liabilities, Noncurrent [Abstract]
Long-Term Liabilities:
Operating Lease, Liability, Noncurrent
Operating lease liability (Note 4)
Warrants and Rights Outstanding
Warrants outstanding
Warrants liability (Note 7)
Liabilities, Noncurrent
Total long-term liabilities
Liabilities
Total liabilities
Stockholders' Equity Attributable to Parent [Abstract]
Stockholders' Deficit:
Common Stock, Value, Issued
Common Stock of $0.00005 par value - Authorized: 250,000,000 shares at December 31, 2025 and 100,000,000 shares at December 31, 2024 respectively; Issued and outstanding: 11,034,775 and 6,141,762 shares at December 31, 2025 and December 31, 2024 respectively
Additional Paid in Capital, Common Stock
Additional paid-in-capital
Treasury Stock, Common, Value
Treasury stocks
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated deficit
Stockholders' Equity Attributable to Parent
Balance
Balance
Total stockholders' deficit
Liabilities and Equity
Total liabilities and stockholders' deficit
Common Stock, Par or Stated Value Per Share
Common stock, par value (in dollars per share)
Common Stock, par value (in dollars per share)
Common Stock, Shares Authorized
Common Stock, shares authorized
Common Stock, Shares, Issued
Common Stock, shares issued
Common Stock, Shares, Outstanding
Common Stock, shares outstanding
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Operating Expenses [Abstract]
Operating expenses:
Research and Development Expense
Research and development
General and Administrative Expense
General and administrative
Operating Income (Loss)
Operating loss
Interest Income (Expense), Nonoperating
Financial expense, net
Fair Value Adjustment of Warrants
Gain on change in fair value of Warrants liability (Note 7)
Decrease in fair value of warrants
Gain on change in fair value of Warrants liability (Note 7)
Net loss
Net loss
Earnings Per Share, Basic
Basic net loss per share (in dollars per share)
Earnings Per Share, Diluted
Diluted net loss per share (in dollars per share)
Weighted Average Number of Shares Outstanding, Basic
Weighted average number of shares outstanding used in computing basic net loss per share (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Weighted average number of shares outstanding used in computing diluted net loss per share (in shares)
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT)
Equity Components [Axis]
Equity Component [Domain]
Common Stock [Member]
Common Stock
Common stock
Additional Paid-in Capital [Member]
Additional paid-in capital
Treasury Stocks [Member]
Treasury stocks
Accumulated Deficit [Member]
Accumulated deficit
Shares, Outstanding
Balance (in shares)
Balance (in shares)
Stock Issued During Period, Value, Issued for Services
Stock-based compensation related to stock granted to service providers
Stock Issued During Period, Shares, Issued for Services
Stock-based compensation related to stock granted to service providers (in shares)
Issuance of common stock
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures
Stock-based compensation related to stock and options granted to directors and employees
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures
Stock-based compensation related to stock and options granted to directors and employees (in shares)
Represents the information pertaining to issuance under at the market.
Issuance Of Share Value
Issuance of shares in at-the-market (ATM) offering (Note 8)
Represents the information pertaining to issuance under at the market.
Issuance Of Shares At The Market
Issuance of shares in at-the-market (ATM) offering (Note 8) (in shares)
Number of shares value for private placement.
Issuance of shares for private placement value
Issuance of shares for private placement (Note 8)
Number of shares issued for private placement.
Issuance of shares for private placement
Issuance of shares for private placement (Note 8) (in shares)
Value of stock issued during the period under a debt for equity swap.
Stock Issued During Period, Value, Debt For Equity Swap
Debt-for-Equity Swap
Number of shares issued during the period under a debt for equity swap.
Stock Issued During Period, Shares, Debt For Equity Swap
Debt-for-Equity Swap (in Shares)
Value of stock issued during the period as a result of exercise of warrants
Stock Issued During Period, Value, Exercise Of Warrants
Exercise of warrants (Note 8)
Number of shares issued during the period as a result of exercise of warrants
Stock Issued During Period, Shares, Exercise Of Warrants
Exercise of warrants (Note 8) (in shares)
CONSOLIDATED STATEMENTS OF CASH FLOWS
Net Cash Provided by (Used in) Operating Activities [Abstract]
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Depreciation
Stock or Unit Option Plan Expense
Stock-based compensation related to options granted to employees and directors
Increase (Decrease) in Operating Lease Liability
Decrease in lease liability
Change in operating lease liability, net
It represents the increase (decrease) during the reporting period in accounts receivable and prepaid expenses.
Increase Decrease In Accounts Receivable and Prepaid Expenses
Decrease (increase) in prepaid expenses and other accounts receivable
Increase (Decrease) in Accounts Payable, Trade
Increase (decrease) in trade payables
The increase (decrease) in the aggregate amount of expenses incurred but not yet paid during the reporting period.
Increase (Decrease) in Accrued Expenses
Increase in accrued expense
Amount of gain (loss) on change in fair value of warrant.
Gain Loss On Change In Fair Value Of Warrant
Gain on change in fair value of warrants (Note 7)
Increase (Decrease) in Accrued Liabilities
Increase (decrease) in employees related liability and accrued expenses
Net Cash Provided by (Used in) Operating Activities
Total net cash used in operating activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment
Purchase of property and equipment
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Total net cash provided by investing activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash flows from financing activities:
Amount of cash inflow from at the market.
Proceeds From At The Market
Proceeds from issuance of shares in at-the-market (ATM) offering (Note 8)
Proceeds from Issuance of Private Placement
Proceeds from Issuance of shares for private placement (Note 8)
Proceeds from Short-Term Debt
Proceeds from short-term loans (Note 11)
Proceeds from issuance of notes payable
Proceeds from Issuance of Warrants
Proceeds from warrants issuance (Note 7)
The amount of cash inflow on settlement of debt through issuance of equity on a debt for equity swap plan.
Proceeds From Issuance of Shares on Settlement Of Debt
Debt-for-Equity Swap
Net Cash Provided by (Used in) Financing Activities
Total net cash provided by financing activities
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Decrease in cash and cash equivalents
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash, cash equivalents and restricted cash at end of the period
Cash, cash equivalents and restricted cash at the beginning of the period
Cash balance
Non-Cash Activities:
The amount of reclassification of warrants liabilities to equity.
Reclassification Of Warrants Liabilities To Equity
Reclassifying the warrants liabilities to equity (Note 8)
GENERAL
Business Description and Basis of Presentation [Text Block]
GENERAL
SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Significant Accounting Policies [Text Block]
SIGNIFICANT ACCOUNTING POLICIES
RESEARCH AND LICENSE AGREEMENT
The entire disclosure on research and license agreement entered by the entity.
Research and License Agreement [Text Block]
RESEARCH AND LICENSE AGREEMENT
LEASES
Lessee, Operating Leases [Text Block]
LEASES
PROPERTY AND EQUIPMENT
Property, Plant and Equipment Disclosure [Text Block]
PROPERTY AND EQUIPMENT
COMMITMENTS AND CONTINGENCIES
Commitments and Contingencies Disclosure [Text Block]
COMMITMENTS AND CONTINGENCIES
WARRANTS LIABILITY
The entire disclosure of warrants liability.
Warrants Liability Disclosure [Text Block]
WARRANTS LIABILITY
STOCK CAPITAL
Stockholders' Equity Note Disclosure [Text Block]
STOCK CAPITAL
FAIR VALUE MEASUREMENT
Fair Value Disclosures [Text Block]
FAIR VALUE MEASUREMENT
TAXES ON INCOME
Income Tax Disclosure [Text Block]
TAXES ON INCOME
SHORT-TERM LOANS
Short-Term Debt [Text Block]
SHORT-TERM LOANS
TRANSACTIONS WITH RELATED PARTIES
Related Party Transactions Disclosure [Text Block]
TRANSACTIONS WITH RELATED PARTIES
SEGMENT REPORTING
Segment Reporting Disclosure [Text Block]
SEGMENT REPORTING
SUBSEQUENT EVENTS
Subsequent Events [Text Block]
SUBSEQUENT EVENTS
Basis of Accounting, Policy [Policy Text Block]
Basis of presentation
Use of Estimates, Policy [Policy Text Block]
Use of estimates
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Financial statements in U.S. dollars
Consolidation, Policy [Policy Text Block]
Principles of consolidation
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and cash equivalents and restricted cash
Property, Plant and Equipment, Policy [Policy Text Block]
Property and equipment
Disclosure of accounting policy for severance Pay.
Severance Pay Policy [Policy Text Block]
Accrued post-employment benefit
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair value of financial instruments
Share-Based Payment Arrangement [Policy Text Block]
Accounting for stock-based compensation
Earnings Per Share, Policy [Policy Text Block]
Basic and diluted net loss per share
Income Tax, Policy [Policy Text Block]
Income taxes
Lessee, Leases [Policy Text Block]
Lease accounting
Disclosure of accounting policy for treasury stock.
Treasury Stock Policy [Policy Text Block]
Treasury Stock
Commitments and Contingencies, Policy [Policy Text Block]
Commitments and Contingencies
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Standards Updates Not Yet Effective and Recently Adopted Accounting Pronouncements
Tabular disclosure of depreciation rates for property, plant and equipment over the estimated useful lives.
Schedule Of Depreciation Rates For Property Plant And Equipment [Table Text Block]
Schedule of annual depreciation rates
Lease, Cost [Table Text Block]
Schedule of supplemental cash flow and total lease cost information
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Schedule of future lease payments under operating leases
Property, Plant and Equipment [Table Text Block]
Schedule of Property, plant and equipment
Share-based Compensation, Stock Options, Activity [Table Text Block]
Summary of the Company's option activity
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]
Schedule of options outstanding have been separated into exercise prices
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
Schedule of restricted stock activity
Tabular disclosure includes the number and weighted-average issue prices for warrants issued to services providers that were outstanding at the beginning and end of the year, and issued during the year.
Schedule Stock Awards Activity Related To Service Providers [Table Text Block]
Schedule of total stock-based compensation expense
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Schedule of assumptions used to determine fair value of July 2023 warrants
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
Schedule significant components of the Company's deferred tax assets
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
Schedule of loss from continuing operations, before taxes on income
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Summary of significant expense categories regularly viewed by CODM
Property, Plant and Equipment [Table]
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset [Domain]
Office Equipment [Member]
Office furniture and equipment
Computer Equipment [Member]
Computer software and electronic equipment
Represents information pertaining to laboratory equipment.
Laboratory Equipment [Member]
Laboratory equipment
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment
Property and equipment
The depreciation rate recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Property Plant and Equipment Depreciation Rates
Property and equipment depreciation rates
Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay
Amount of severance pay equal to monthly deposits
Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is covered by a valid claim or is covered by orphan drug status.
Percentage of Royalty Payment if Licensed Product Covered by Valid Claim or Orphan Drug Status
Percentage of royalty payment if licensed product covered by valid claim or orphan drug status
Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is not covered by a valid claim or is not covered by orphan drug status.
Percentage of Royalty Payment If Licensed Product Not Covered by Valid Claim or Orphan Drug Status
Percentage of royalty payment if licensed product not covered by valid claim or orphan drug status
This element represents the validity of the royalties' payments by the company not covered by a Valid Claim or Orphan Drug Status in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Validity of Royalty Payment Not Covered by Valid Claim or Orphan Drug Status
Validity of royalty payment not covered by valid claim or orphan drug status
Lessee, Lease, Description [Table]
Consolidated Entities [Axis]
Consolidated Entities [Domain]
Subsidiaries [Member]
Representing information pertaining to Brainstorm Cell Therapeutics, Ltd. a wholly-owned subsidiary formed in Israel, which conducts all of the research and development activities of the company.
BCT [Member]
BCT
Lessee, Lease, Description [Line Items]
LEASES
Area of Land
Area of land
Lessee, Operating Lease, Term of Contract
Term of lease
Lessee, Operating Lease, Renewal Term
Extension term of lease
Sale Leaseback Transaction, Monthly Rental Payments
Monthly lease payments
The increase (decrease) during the period in the operating lease right of use asset.
Increase (Decrease) in Operating Lease Right Of Use Asset
Decrease in ROU
Operating Lease, Liability
Operating lease liability
Total lease liability balance
Lease, Cost
Lease costs
Operating Lease, Weighted Average Remaining Lease Term
Operating lease, weighted average remaining lease term
Operating Lease, Weighted Average Discount Rate, Percent
Operating lease, weighted average discount rate percent
Operating Lease, Payments
Cash payments for operating leases
The amount of operating lease expense (income).
Operating Lease Expense (Income)
Operating lease expense
The amount of finance lease expense (income).
Finance Lease Expenses (Income)
Finance lease expense (income)
Lessee, Operating Lease, Liability, to be Paid, Year One
2026
Lessee, Operating Lease, Liability, to be Paid
Total future lease payments
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less imputed interest
Leasehold improvements
Property, Plant and Equipment, Net [Abstract]
Composition:
Property, Plant and Equipment, Gross
Cost
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Accumulated depreciation
Loss Contingencies [Table]
Statistical Measurement [Axis]
Statistical Measurement [Domain]
Minimum [Member]
Minimum
Maximum [Member]
Maximum
Legal Entity [Axis]
Entity [Domain]
Represents information pertaining to Israel innovation authorities.
Israel Innovation Authorities [Member]
Israel Innovation Authorities
Loss Contingencies [Line Items]
COMMITMENTS AND CONTINGENCIES
The percentage of royalty payments obligated to be paid as per the agreement for grants received for participation in research
Percentage Of Royalty Payments Agreed For Grants
Percentage of royalty payments agreed for grants
The underlying basis on which the grants are linked.
Grants Underlying Basis
Grants underlying basis
The cash inflow from grants received during the period.
Amounts Of Grants Received
Amounts of grants received
Class of Warrant or Right [Table]
Warrant [Member]
Private placement warrants
Class of Warrant or Right [Axis]
Class of Warrant or Right [Domain]
Represents the information pertaining to July 2023 warrants.
July 2023 Warrants [Member]
July 2023 warrants
Class of Warrant or Right [Line Items]
WARRANTS LIABILITY
Stock Issued During Period, Shares, New Issues
Aggregate shares sold
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Warrants to purchase shares of common stock
The cash inflow associated with the amount received from issuance of common stock and from holders exercising their stock warrants.
Proceeds from Issuance of Common Stock and Warrants Exercises
Gross proceeds
Liabilities, Fair Value Disclosure
Fair value of warrants
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Sale of Stock [Axis]
Sale of Stock [Domain]
This member represents at market offering.
At Market Offering [Member]
At Market Offering
Option Indexed to Issuer's Equity, Type [Axis]
Option Indexed to Issuer's Equity, Type [Domain]
This member stands for Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014.
Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014 [Member]
Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014
Restricted Stock [Member]
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
STOCK CAPITAL
Stockholders' Equity Note, Stock Split, Conversion Ratio
Reverse stock split
Stock Issued During Period, Value, New Issues
Aggregate offering amount
The cash inflow before payment of issuance costs, from the additional capital contribution to the entity.
Gross Proceeds From Issuance of Common Stock
Gross proceeds
Payments of Stock Issuance Costs
Issuance costs
Proceeds from Issuance of Common Stock
Net proceeds
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized
Shared pool of shares of the Common Stock available for issuance
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized
Number of shares authorized
Additional extended term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Additional Extended Term
Additional extend the term (in years)
Common Stock, Capital Shares Reserved for Future Issuance
Future issuance of common stock
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Unrecognized compensation cost
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Weighted average period
Stock Repurchased During Period, Shares
Shares repurchased
Stock Repurchased During Period, Value
Value of shares repurchased
Share-based Compensation
Compensation expense
Total stock-based compensation expense
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Represents the information pertaining to securities purchase agreement.
Securities Purchase Agreement [Member]
Securities purchase agreement
Represents the information pertaining to public offering.
Public Offering [Member]
Public offering
Represents the information pertaining to the pre funded warrants.
Pre Funded Warrants [Member]
Pre Funded Warrants
Represents the information pertaining to the unregistered warrants.
Unregistered Warrants [Member]
Unregistered Warrants
Subsequent Event Type [Axis]
Subsequent Event Type [Domain]
Subsequent Event [Member]
Subsequent events
Shares Issued, Price Per Share
Purchase price per share
Share issue price
Class of Warrant or Right, Exercise Price of Warrants or Rights
Class of Warrant or Rights, Exercise Price of Warrants or Rights
Warrants issue price per unit
Proceeds from Issuance or Sale of Equity
Gross proceeds
The period after the issuance date, the warrants become exercisable.
Class of Warrant or Right, Exercisable Period
After issuance date, warrants become exercisable (in months)
Warrants and Rights Outstanding, Term
Warrants term
Class of Warrant or Right, Exercise price
Class of warrant exercise price
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Number of shares issued on exercise of each warrant
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Amount of options, Outstanding at end of period
Amount of options, Outstanding at beginning of period
Options outstanding at end of period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
Amount of options, Exercised
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Amount of options, Forfeited
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Options exercisable
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number
Amount of options, Vested at end of period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted average exercise price, Outstanding at end of period (in dollars per share)
Weighted average exercise price, Outstanding at beginning of period (in dollars per share)
Exercise price (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Weighted average exercise price, Exercised (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Weighted Average exercise Price, Forfeited (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price
Weighted average exercise price, Vested at end of period (in dollars per share)
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table]
Exercise Price Range [Axis]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain]
Represents information pertaining to exercise price $11.25.
Exercise Price 11.25 [Member]
Exercise Price 11.25
Represents information pertaining to exercise price $25.95.
Exercise Price 25.95 [Member]
Exercise Price 25.95
Represents information pertaining to exercise price $36.75.
Exercise Price 36.75 [Member]
Exercise Price 36.75
Represents information pertaining to exercise price $45.60.
Exercise Price 45.60 [Member]
Exercise Price 45.60
Represents information pertaining to exercise price $61.35.
Exercise Price 61.35 [Member]
Exercise Price 61.35
Represents information pertaining to exercise price $142.65.
Exercise Price 142.65 [Member]
Exercise Price 142.65
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
STOCK CAPITAL
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Weighted average remaining contractual Life - Years
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Number of Shares of Restricted Stock, Nonvested at end of period
Number of Shares of Restricted Stock, Nonvested at beginning of period
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Nonvested at end of period
Weighted Average Grant Date Fair Value, Nonvested at beginning of period
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Granted
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Forfeited
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Weighted Average Remaining Contractual Term (Years), Nonvested
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Income Statement Location [Axis]
Income Statement Location [Domain]
Research and Development Expense [Member]
Research and development
General and Administrative Expense [Member]
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
STOCK CAPITAL
Fair Value Measurement Inputs and Valuation Techniques [Table]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Domain]
Fair Value, Inputs, Level 3 [Member]
Level 3
Measurement Input Type [Axis]
Measurement Input Type [Domain]
Measurement Input, Maturity [Member]
Time to expiration
Measurement Input, Share Price [Member]
Common stock price
Measurement Input, Risk Free Interest Rate [Member]
Risk-free interest rate
Measurement Input, Price Volatility [Member]
Volatility
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
FAIR VALUE MEASUREMENT
Warrants and Rights Outstanding, Measurement Input
Warrants liabilities, inputs
Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount, Noncurrent
Warrants liability
Tax Credit Carryforward [Table]
Income Tax Authority [Axis]
Income Tax Authority [Domain]
Foreign Tax Authority [Member]
Israel
Domestic Tax Authority [Member]
U.S.
Tax Credit Carryforward [Line Items]
TAXES ON INCOME
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent
Corporate tax rate
Deferred Tax Assets, Valuation Allowance
Valuation allowance
Deferred tax assets, valuation allowance
Tax Credit Carryforward, Amount
Accumulated tax loss carryforward
Operating Loss Carryforwards
Operating loss carryforward
Deferred Tax Assets, Gross
Net deferred tax asset before valuation allowance
Deferred Tax Assets, Net of Valuation Allowance
Net deferred tax asset
Income (Loss) from Continuing Operations before Income Taxes, Domestic
United States
Income (Loss) from Continuing Operations before Income Taxes, Foreign
Israel
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Loss from continuing operations, before taxes on income
Short-Term Debt [Table]
Short-Term Debt, Type [Axis]
Short-Term Debt, Type [Domain]
Represents information pertaining to convertible promissory note issued on October 31, 2025.
Convertible Promissory Note Issued On October 31, 2025 [Member]
Convertible promissory note, October 31, 2025
Represents information pertaining to convertible promissory note issued on November 10, 2025.
Convertible Promissory Note Issued On November 10, 2025 [Member]
Convertible promissory note, November 10, 2025
Represents information pertaining to convertible promissory note issued on November 20, 2025.
Convertible Promissory Note Issued On November 20, 2025 [Member]
Convertible promissory note, November 20, 2025
Represents information pertaining to short term loan agreement.
Loan agreement
Short-Term Debt [Line Items]
SHORT-TERM LOANS
Debt Instrument, Face Amount
Principal amount
Debt Instrument, Unamortized Discount, Current
Issued discount
Debt Instrument, Fee Amount
Legal fees and due diligence fees
The maximum percentage of a company's outstanding shares that a holder of a convertible debt instrument is allowed to beneficially own after conversion.
Debt Instrument, Convertible, Beneficial Ownership Limitation, Percentage
Beneficial ownership limitation, percentage
Number of installments within which the company has to be make repayments under debt agreement.
Debt Instrument, Number Of Installments
Number of installments
Debt Instrument, Periodic Payment, Principal
Debt instrument periodic payment principal
Percentage points added to the reference rate to compute the variable rate on the debt instrument.
Debt Instrument, Convertible, Conversion Price Determination, Percentage Discount Applied on Lowest Trading Price
Debt instrument conversion on discount applied on lowest trading price percentage
Threshold trading days used to determine the lowest stock price for calculating the conversion price.
Debt Instrument, Convertible, Conversion Price Determination, Threshold Period Of Trading Days
Trading days prior to the conversion
Debt Instrument, Interest Rate, Stated Percentage
Interest rate percentage
Contractual interest rate
Contractual interest rate for funds borrowed, under the debt agreement applicable in the event of default.
Debt Instrument, Default Interest Rate, Percentage
Interest rate increases, percentage
Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Short-Term Debt, Maturity, Repayments In Four Months
Repayments of short-term debt maturity in four months
Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fifth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Short-Term Debt, Maturity, Repayments In Five Months
Repayments of short-term debt maturity in five months
Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in sixth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Short-Term Debt, Maturity, Repayments In Six Months
Repayments of short-term debt maturity in six months
Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in seventh month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Short-Term Debt, Maturity, Repayments In Seven Months
Repayments of short-term debt maturity in seven months
Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in eighth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Short-Term Debt, Maturity, Repayments In Eight Months
Repayments of short-term debt maturity in eight months
Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in ninth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Short-Term Debt, Maturity, Repayments In Nine Months
Repayments of short-term debt maturity in nine months
Amount of short-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in tenth month following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Short-Term Debt, Maturity, Repayments In Ten Months
Repayments of short-term debt maturity in ten months
Number of days from the debt issue date until the first scheduled installment payment is due under the debt instrument.
Debt Instrument, Initial Installment Due
Initial installment due for debt instrument
Number of days between each consecutive scheduled installment payment under the debt instrument following the initial deferral period.
Debt Instrument, Subsequent Installment Interval
Subsequent installment interval for debt instrument
Period following the initial installment deferral period, during which scheduled debt payments are required under the debt instrument.
Debt Instrument, Subsequent Monthly Installment Periods
Subsequent monthly installment periods for debt instrument
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table]
Segments [Axis]
Segments [Domain]
Represents information pertaining to single reportable segment.
Single Reportable Segment [Member]
Single reportable segment
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
SEGMENT REPORTING
Number of Reportable Segments
Number of reportable segment
Research and Development Expense [Abstract]
Research and Development expenses:
Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit incurred under research and development.
Research and Development, Labor and Related Expense
Payroll and payroll related
Amount of fees paid to subcontractors and consultants under research and development.
Research and Development, Subcontractors and Consultants
Subcontractors and consultants
Other Research and Development Expense
Other
General and Administrative Expense [Abstract]
General and Administrative expenses
Labor and Related Expense
Payroll and payroll related
Professional Fees
Professional services
Other General and Administrative Expense
Other
Segment Reporting Information, Additional Information [Abstract]
Other segment items:
Share-Based Payment Arrangement, Expense
Share-based payments
Subsequent Event [Table]
Convertible Notes Payable [Member]
Unsecured promissory note
Private Placement [Member]
Private Placement
Represents information pertaining to common warrants.
Common Warrants [Member]
Common warrants
Subsequent Event [Line Items]
SUBSEQUENT EVENTS
Number of securities purchase agreement entered to issue debt instrument to each investors.
Debt Instrument, Number Of Purchase Agreement To Each Investor
Debt issuance, number of securities purchase agreement
Number of debt instruments issued to each investor.
Debt Instrument, Number Of Instruments Issued To Each Investor
Number of instruments issued
Number of accredited investors to whom each debt instruments were issued.
Debt Instrument, Number Of Accredited Investors For Each Instrument
Number of accredited investors
Maximum additional borrowing capacity under a debt instrument.
Debt Instrument, Maximum Additional Borrowing Capacity, Amount
Maximum additional borrowing capacity
Number of installments required to repay the debt amount.
Debt Instrument, Repayments, Number Of Installments
Number of installments
Optional period at specified discounts given to the borrower for early repayment of debt.
Debt Instrument, Optional Prepayment Period
Optional repayment period
Interest rate as percentage of outstanding obligations for funds borrowed in the event of default.
Debt Instrument, Debt Default, Interest Rate As Percentage Of Outstanding Obligations
Interest rate in event of default
Percentage discount applied on lowest trading price in determination of conversion price of convertible debt instrument in the event of default.
Debt Instrument, Debt Default, Conversion Price Determination, Percentage Discount Applied On Lowest Trading Price
Debt default conversion, discount on lowest trading price
Threshold number of trading days as look back period considered in determination of conversion price of convertible debt instrument in the event of default.
Debt Instrument, Debt Default, Conversion Price Determination, Threshold Look Back Period Of Trading Days
Debt default conversion, look back period
Percentage of potential payments in the event of default to be made by the issuer of debt instrument.
Debt Instrument, Debt Default, Potential Payment, Percentage
Debt default, percentage of potential payment
Debt Instrument, Term
Term
Period during which the issuer is not required to make any scheduled repayments of the debt instruments.
Debt Instrument, Non-Amortization Period
Non-amortization period
Percentage discount applied on trading price in determination of conversion price of convertible debt instrument.
Debt Instrument, Convertible, Conversion Price Determination, Percentage Discount Applied On Trading Price
Debt conversion, discount on trading price
The eligibility period for conversion of convertible debt instrument.
Debt Instrument, Convertible, Conversion Eligibility Period
Conversion eligibility period
The percentage of proceeds from future financings that a lender is entitled (or required) to receive or have applied toward repayment of a debt instrument.
Debt Instrument, Lender Right To Claim On Future Financing, Percentage
Right to sweep, percentage
The minimum amount of proceeds from a future financing that must be raised for the lender's right to claim a specified percentage of the proceeds to apply toward repayment of the debt instrument to be triggered.
Debt Instrument, Lender Right To Claim On Future Financing, Threshold Proceed Amount
Threshold proceeds to trigger right
Number of securities purchase agreement entered to offer securities in an offering to investor.
Issue Of Securities, Number Of Purchase Agreement
Securities issuance, number of securities purchase agreement
Maximum aggregate offering price of securities agreed to be issued under the security purchase agreement.
Issue Of Securities, Maximum Aggregate Offering Price
Maximum aggregate issuance
Number of securities into which the class of warrant or right may be converted expressed as percentage of purchased units.
Class of Warrant or Right, Number of Securities Called by Warrants or Rights, Percentage Of Purchased Units
Warrant exercisable, percentage of purchased units
n/a
Rule 10b5-1 Arrangement Modified [Flag]
Rule 10b5-1 Arrangement Modified
n/a
Non-Rule 10b5-1 Arrangement Modified [Flag]
Non-Rule 10b5-1 Arrangement Modified